Oral rimegepant for migraine prevention

Lars Edvinsson

doi:10.1016/S0140-6736(20)32624-6

Oral rimegepant for migraine prevention

3 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Lancet
Vol/bind	397
Udgave nummer	10268
Sider (fra-til)	4-5
Antal sider	2
ISSN	0140-6736
DOI	https://doi.org/10.1016/S0140-6736(20)32624-6
Status	Udgivet - 2 jan. 2021
Udgivet eksternt	Ja

Adgang til dokumentet

10.1016/S0140-6736(20)32624-6

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{808dd8dc65b14fae9351cc71cadb7e83,

title = "Oral rimegepant for migraine prevention",

keywords = "Calcitonin Gene-Related Peptide Receptor Antagonists, Double-Blind Method, Humans, Migraine Disorders/prevention & control, Piperidines, Pyridines",

author = "Lars Edvinsson",

year = "2021",

month = jan,

day = "2",

doi = "10.1016/S0140-6736(20)32624-6",

language = "English",

volume = "397",

pages = "4--5",

journal = "Lancet",

issn = "0140-6736",

publisher = "Elsevier BV",

number = "10268",

}

TY - JOUR

T1 - Oral rimegepant for migraine prevention

AU - Edvinsson, Lars

PY - 2021/1/2

Y1 - 2021/1/2

KW - Calcitonin Gene-Related Peptide Receptor Antagonists

KW - Double-Blind Method

KW - Humans

KW - Migraine Disorders/prevention & control

KW - Piperidines

KW - Pyridines

UR - http://www.scopus.com/inward/record.url?scp=85098652613&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(20)32624-6

DO - 10.1016/S0140-6736(20)32624-6

M3 - Comment/debate

C2 - 33338436

SN - 0140-6736

VL - 397

SP - 4

EP - 5

JO - Lancet

JF - Lancet

IS - 10268

ER -